Clinical trial
A Retrospective, Multi-Center, Observational Study to Assess the Effect of Tecfidera® Delayed-Release Capsules on Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis (REALIZE)
NCT02519413 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective, Multi-Center, Observational Study to Assess the Effect of Tecfidera® Delayed-Release Capsules on Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis (REALIZE)
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- February 29, 2016
- Enrollment
- 483 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.